Skip to content

AFFILIATES:

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Menu
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Brookline Capital Markets
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT
Menu
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT

Advisory

Imunon Capital Markets Advisory Ending May 22

Read More Imunon Capital Markets Advisory Ending May 22Continue

Journey Medical Capital Markets Advisory Ending May 22

Read More Journey Medical Capital Markets Advisory Ending May 22Continue

CNS

Read More CNSContinue

Cellectar Biosciences Jul 18

Read More Cellectar Biosciences Jul 18Continue

Hepion Pharmaceuticals Capital Markets Advisory Ending Mar 22

Read More Hepion Pharmaceuticals Capital Markets Advisory Ending Mar 22Continue

MEI Pharma Ending Feb 22

Read More MEI Pharma Ending Feb 22Continue

ContraFect

Read More ContraFectContinue

Valeritas

Read More ValeritasContinue

Aquestive July 2018

Read More Aquestive July 2018Continue

Q BioMed

Read More Q BioMedContinue

Page navigation

Previous PagePrevious 1 … 3 4 5 6 7 8 Next PageNext

HEADQUARTERS

Brookline Capital Markets

600 Lexington Avenue, 30th Floor
New York, New York 10022
(646) 603-6716

Linkedin

LINKS

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Securities Offered Through Arcadia Securities, LLC – Member FINRA/SIPC

FINRA BROKER CHECK

Arcadia Securities LLC Form CRS

Arcadia Securities LLC Reg BI

Order routing information can be accessed through the following link by inputting Arcadia Securities: https://www.orderroutingdisclosure.com/.

© 2025 Brookline Capital Markets. All rights reserved

© 2021 Brookline Capital Markets. All rights reserved